Evidence map›Paper›PMID 39362358›Full record

ArticleCryobiology2024

Vitreous tissue cryopreservation using a blood vessel model and cryomacroscopy for scale-up studies: Observations and mathematical modeling.

Michael J Taylor, Prem K Solanki, Zhenzhen Chen, Simona Baicu, Christina Crossley, Elizabeth D Greene, Lia H Campbell, Kelvin G M Brockbank, Yoed Rabin

Abstract read
In one paragraph

Article in Cryobiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Michael J TaylorDepartment of Mechanical Engineering, Carnegie Mellon University, Pittsburgh, PA, USA; Sylvatica Biotech. Inc, N. Charleston, SC, USA; Tissue Testing Technologies LLC, N. Charleston, SC, USA.
Prem K SolankiDepartment of Mechanical Engineering, Carnegie Mellon University, Pittsburgh, PA, USA.
Zhenzhen ChenTissue Testing Technologies LLC, N. Charleston, SC, USA.
Simona BaicuSylvatica Biotech. Inc, N. Charleston, SC, USA.
Christina CrossleyTissue Testing Technologies LLC, N. Charleston, SC, USA.
Elizabeth D GreeneTissue Testing Technologies LLC, N. Charleston, SC, USA.
Lia H CampbellTissue Testing Technologies LLC, N. Charleston, SC, USA.
Kelvin G M BrockbankTissue Testing Technologies LLC, N. Charleston, SC, USA; Department of Bioengineering, Clemson University, Clemson, SC, USA.
Yoed RabinDepartment of Mechanical Engineering, Carnegie Mellon University, Pittsburgh, PA, USA. Electronic address: rabin@cmu.edu.

Funding

Cryopreservation mechanisms in blood vessels using ice modulatorsR01HL127618 · NHLBI · CARNEGIE-MELLON UNIVERSITY · PI RABIN, YOED · 2015 to 2018
$1.6M
NHLBI NIH HHS R01 HL127618
6 · The paper itself

Abstract

Successful long-term cryobanking of multicellular tissues and organs at deep subzero temperatures calls for the avoidance of ice cryoinjury by reliance upon ice-free cryopreservation techniques. However, the quality of the cryopreserved material is the direct result of its ability to survive a host of harmful mechanisms, chief among which is overcoming the trifecta effects of ice crystallization, toxicity, and mechanical stress. This study aims at exploring improved conditions to scale-up ice-free cryopreservation by combining DP6 as a base cryoprotective agent (CPA) solution with an array of synthetic ice modulators (SIMs). This study is conducted by integrating cryomacroscopy techniques, thermal modeling, solid mechanics analysis, and viability and contractility investigation to correlate physical effects, thermal outcomes, and cryobiology results. As an extension of previous work, this study aims at scale-up of established baseline blood vessel models, while comparing the relative toxicity and vitreous stability of 4 ml and 10 ml samples of DP6 containing either sucrose as a SIM, or the commercial synthetic ice blockers (X1000 and Z1000). Using that established protocol, the addition and removal of DP6+0.6M sucrose and DP6 + 1% X1000 + 1% Z1000 were both well tolerated in rabbit carotid and pig femoral artery models, when assessed for metabolic recovery and contractility. Using cryomacroscopy, it was demonstrated that DP6 + 0.6M sucrose provided a stable vitrification medium under marginal cooling and warming conditions that resulted in >50% survival rate. By contrast, DP6 + 1% X1000 + 1% Z1000 was subject to visible ice formation during cooling under the same thermal conditions, resulting in a significantly lower recovery of ∼20%. Thermal modeling is used in this study to verify the actual cooling and rewarming rates in the specimens, while thermomechanics analysis is used to explain why fractures were observed using cryomacroscopy when the specimens were contained in glass vials but not in plastic vials.

Indexed as

CryopreservationCryoprotective AgentsIceAnimalsBlood VesselsModels, TheoreticalRabbitsSucroseSwineVitrificationCryoprotective AgentsIceSucroseBlood vesselsContractilityCryomacroscopyIce-free cryopreservationPhysical effectsThermo-mechanicsViabilityVitrification

Identifiers

PMID39362358
PMCPMC12976967

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.